Prostate Cancer - 3-D Diagnosis and Targeted Focal Therapy

International Program for 3-D Diagnosis & Therapy of Prostate Cancer

David Raben, MD

Associate Professor

Department of Radiation Oncology



Bowman Gray School of Medicine



University of Hawaii

Johns Hopkins Hospital


 David Raben, MD, is an Associate Professor and Associate Scientist in the Department of Radiation Oncology at the University Colorado Comprehensive Cancer Center, Aurora, Colorado. Dr. Raben received his medical degree from the Bowman Gray School of Medicine, Wake Forest University, Winston Salem, North Carolina, and completed his residency in Radiation Oncology at Johns Hopkins University, Baltimore, Maryland.

 David Raben, MD
David Raben, MD


At present he is an associate scientist and associate professor in the Department of Radiation Oncology at the University of Colorado Cancer Center. Dr. Raben has established himself in the area of translational research combining radiation with biologic agents that alter the cancer cell growth cycle to enhance the effectiveness of radiation therapy for head and neck cancer.  Dr. Raben is board certified, active member of the American College of Radiology, American Society for Therapeutic Radiology and Oncology, American Society of Clinical Oncology and the American Association of Cancer Research.  Dr. Raben serves on the Translational Research Committee of the Radiation Therapy Oncology Group, American Society for Therapeutic Radiology and Oncology (ASTRO) Educational Committee, ASCO publications committee, the Southwest Oncology Group Radiation Oncology Committee and University of Colorado Cancer Committee. He also participates in the Young Leadership committee of ASTRO. He has been a participating or lead author in 42 published articles and is an adhoc reviewer for the American Journal of Clinical Oncology, Clinical Cancer Research, International Journal of Radiation Oncology Biology Physics, British Journal of Cancer, and Head and Neck.  He is currently on the editorial board of the JCO, Signal and International Journal of Cancer.


PUBLICATIONS:   Journal Articles in Pub Med (